StockData
Innoviva, Inc. logo

Innoviva, Inc. (INVA) stock

INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3038% below fair value
$18.41+0.01 (+0.05%)

Close on Nov 19, 2026Market cap $1.33BP/E 9.3Yield –

Innoviva shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Innoviva's shares outstanding was 72M at Sep 30, 2026. For fiscal 2025 it was 85M, up 14.3% from the year before. Over ten years it grew -3.0% a year on average. The highest annual figure on record is 123M in fiscal 2016.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202585M+14.3%
FY2024Dec 31, 202474M-14.6%
FY2023Dec 31, 202387M-8.8%
FY2022Dec 31, 202295M+1.0%
FY2021Dec 31, 202194M-16.9%
FY2020Dec 31, 2020114M+0.1%
FY2019Dec 31, 2019113M+0.0%
FY2018Dec 31, 2018113M-5.4%
FY2017Dec 31, 2017120M-2.7%
FY2016Dec 31, 2016123M+6.8%
FY2015Dec 31, 2015115M+3.0%
FY2014Dec 31, 2014112M+9.4%
FY2013Dec 31, 2013102M+12.7%
FY2012Dec 31, 201291M+10.8%
FY2011Dec 31, 201182M+13.8%
FY2010Dec 31, 201072M+14.3%
FY2009Dec 31, 200963M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 202672M-15.2%
Q2 FY2026Jun 30, 202673M-13.1%
Q1 FY2026Mar 31, 202685M+35.3%
Q4 FY2025Dec 31, 202585M-20.8%
Q3 FY2025Sep 30, 202585M+35.0%
Q2 FY2025Jun 30, 202584M+35.1%
Q1 FY2025Mar 31, 202563M-25.8%
Q4 FY2024Dec 31, 2024108M+26.7%
Q3 FY2024Sep 30, 202463M-26.9%
Q2 FY2024Jun 30, 202463M-4.5%
Q1 FY2024Mar 31, 202485M-5.9%
Q4 FY2023Dec 31, 202385M-11.3%
Q3 FY2023Sep 30, 202386M-10.1%
Q2 FY2023Jun 30, 202365M-31.5%
Q1 FY2023Mar 31, 202390M-4.2%
Q4 FY2022Dec 31, 202296M+17.3%
Q3 FY2022Sep 30, 202296M+17.3%
Q2 FY2022Jun 30, 202296M-5.0%
Q1 FY2022Mar 31, 202294M-17.5%
Q4 FY2021Dec 31, 202182M-28.1%
Q3 FY2021Sep 30, 202182M-28.1%
Q2 FY2021Jun 30, 2021101M-11.4%
Q1 FY2021Mar 31, 2021114M+0.1%
Q4 FY2020Dec 31, 2020114M+0.1%
Q3 FY2020Sep 30, 2020114M+0.1%
Q2 FY2020Jun 30, 2020114M+0.1%
Q1 FY2020Mar 31, 2020114M+0.1%
Q4 FY2019Dec 31, 2019113M+0.1%
Q3 FY2019Sep 30, 2019113M+0.0%
Q2 FY2019Jun 30, 2019113M-0.0%
Q1 FY2019Mar 31, 2019113M-0.2%
Q4 FY2018Dec 31, 2018113M-4.9%
Q3 FY2018Sep 30, 2018113M-5.4%
Q2 FY2018Jun 30, 2018113M-5.9%
Q1 FY2018Mar 31, 2018114M-5.6%
Q4 FY2017Dec 31, 2017119M-24.7%
Q3 FY2017Sep 30, 2017120M–
Q2 FY2017Jun 30, 2017120M–
Q1 FY2017Mar 31, 2017120M–
Q4 FY2016Dec 31, 2016158M–

More Innoviva figures

See a number that looks wrong?